Ipsen J, Rosazza J P
J Nat Prod. 1984 May-Jun;47(3):497-503. doi: 10.1021/np50033a016.
Microbial transformation experiments were conducted using 3-ketoaphidicolin (2) as a starting material. Metabolites were isolated by solvent extraction and chromatography, and structures were elaborated by cmr and pmr spectroscopy, ms, and ir analyses. Several microorganisms provided metabolites in excellent yields, including 3-epiaphidicolin (4), 6 beta-hydroxy-3-ketoaphidicolin (5), and 19-nor-16,17-dihydroxyaphidicolan-3-one (6). The last compound is formed via oxidation of the primary alcohol functional group at position 18 to the corresponding beta-keto acid derivative which spontaneously decarboxylates. This reaction is analogous to the metabolic demethylation of sterol intermediates. Each metabolite was tested for antitumor activity in the P-388 leukemic test system, and in the 6C631 colon tumor model system. None of the compounds were active in vivo, and all were less active than aphidicolin in the in vitro P-388 test system.
以3-酮基阿非迪考林(2)为起始原料进行了微生物转化实验。通过溶剂萃取和色谱法分离代谢产物,并通过碳核磁共振(cmr)、质子核磁共振(pmr)光谱、质谱(ms)和红外(ir)分析确定其结构。几种微生物产生的代谢产物产率很高,包括3-表阿非迪考林(4)、6β-羟基-3-酮基阿非迪考林(5)和19-降-16,17-二羟基阿非迪考兰-3-酮(6)。最后一种化合物是通过将18位的伯醇官能团氧化为相应的β-酮酸衍生物,然后该衍生物自发脱羧形成的。该反应类似于甾醇中间体的代谢去甲基化反应。对每种代谢产物在P-388白血病测试系统和6C631结肠肿瘤模型系统中进行了抗肿瘤活性测试。这些化合物在体内均无活性,并且在体外P-388测试系统中,它们的活性均低于阿非迪考林。